Clinical Trial Update: Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update studying prevention of recurrent ulcer bleeding in patients with idiopathic gastroduodenal ulcer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Peptic Ulcer Disease
• Gi Bleeding
• Idiopathic Gastroduodenal Ulcer

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Active Peptic Ulcer Disease/GI Bleeding | Phase 4 | Status: RECRUITING